Stock Market News3 weeks MRK Gets Positive CHMP Nod for 21-Valent Pneumococcal Jab Capvaxive Zacks
The Committee for Medicinal Products for Human Use recommends approval for Merck’s pneumococcal 21-valent conjugate vaccine, Capvaxive.
XThe Committee for Medicinal Products for Human Use recommends approval for Merck’s pneumococcal 21-valent conjugate vaccine, Capvaxive.
X